Advertisement

Topics

Companies Related to "Cell type switch helps colon cancer evade treatment" [Most Relevant Company Matches] RSS

05:04 EST 17th December 2018 | BioPortfolio

Here are the most relevant search results for "Cell type switch helps colon cancer evade treatment" found in our extensive corporate database of over 50,000 company records.

Showing "Cell type switch helps colon cancer evade treatment" Companies 1–25 of 6,900+

Extremely Relevant

Intracel

Intracel is a leading commercial-stage biotechnology company focused on the development of immune therapy to treat cancer. The company’s pipeline includes product development programs in active immunotherapy and fully human monoclonal antibodies. Intracel has completed clinical studies in Colon, Renal and Ovarian carcinoma, as well as Melanoma. Business StrategyRestructured company to focus o...


PREVEA clinic

Prevea Clinic wants you to stay "50+ and fabulous." Consider scheduling a colonoscopy (colon cancer screening) once every ten years beginning at age 50. If you have a personal or family history of colon cancer, connect with your physician for a personal recommendation. Many insurance plans cover colonoscopy. Up to 90 percent of colon cancers can be prevented by removing colon polyps before they be...

Relevant

StopColonCancerNow.com

StopColonCancerNow.com is a community of more than 700 physicians who have joined forces to promote education and awareness about colon cancer screening and prevention. AmSurg, provider of approximately one in every 10 colonoscopies in the United States, launched the campaign in 2009 as part of its commitment to provide the highest level of care and inform...


Onconome, Inc.

Onconome is dedicated to the discovery, development and commercialization of innovative biomarkers for the early and accurate detection of prostate, colon, bladder and other forms of cancer, including lung, breast, liver, pancreatic and stomach. Early detection is the key to successful treatment. Our serum tests for early detection of prostate and colon cancer and our urine test for bladder cancer...

Report Card Coalition

Launched in 2004, the Colorectal Cancer Legislation Report Card initiative is supported by a coalition that includes American Cancer Society Cancer Action Network, American College of Gastroenterology, American Gastroenterological Association, American Society of Colon and Rectal Surgeons, American Society for Gastrointestinal Endoscopy, the Cancer Support Community, C3: Colorectal Cancer Coalitio...

Matritech

Matritech, Inc. develops, manufactures and markets innovative cancer diagnostic products based on its proprietarynuclear matrix protein ("NMP") technology. The nuclear matrix, a three dimensional protein framework within the nucleus of cells, plays a fundamental role in determining cell type by physically organizing the contents of the nucleus, including DNA. The Company has demonstrated that th...

Cell Works Incorporated

Cell Works Inc. is an early-stage biomedical company located in Baltimore, Maryland, basing their initial products on research conducted at The Johns Hopkins University (JHU). Cell Works has exclusively licensed certain cell isolation technology from JHU on a worldwide basis. This technology license currently incorporates one patent, one patent application, and related international patent applica...

Tolerx, Inc.

Tolerx, Inc., a world leader in the understanding of T cell function, is developing novel therapies intended to treat autoimmune diseases, diabetes, and cancer by specifically modulating T cell activity. The company's pipeline includes its lead candidate, otelixizumab, a targeted T cell immunomodulator in Phase 3 development for the treatment of type 1 diabetes that is partnered with GlaxoSmithKli...

Cancer Prevention Pharmaceuticals, Inc.

Cancer Prevention Pharmaceuticals, Inc. (CPP) is developing therapeutics designed to reduce the risk of cancer and other diseases. CPP’s pharmaco-prevention approach has been used with success in other disease categories such as cardiovascular, neurovascular, and infectious disease. In addition to the CPP FAP-310 trial, CPP is co-sponsoring with the N...

Bandaid Surgery, PC

Laparoscopic colon surgery, also known as band-aid colon surgery, is a revolutionary colorectal surgical technique pioneered and perfected by Dr.David Blumberg, a Board Certified General and Colorectal Surgeon while in the Department of Surgery at the University of Pittsburgh Medical Center. Company Overview: Band-aid colon surgery is a revolutionary colorectal surgical technique pioneered...

Tau Therapeutics LLC

Tau Therapeutics is a clinical stage company developing oncology drugs for solid tumors that selectively inhibit the T-type calcium channel – a novel mechanism of action for cancer. The company’s approach, called Interlaced Therapy™, capitalizes on the central role of calcium influx through T-type calcium channels during cancer cell growth. T-type ...

RC Cancer Centers

Each year thousands of patients from around the world and across the United States turn to RC Cancer Centers seeking a cure for their prostate cancer and learn why they are The Choice for Saving Lives. Founded in 1979, Radiotherapy Centers of Georgia, a division of RC Cancer Centers, has earned a reputation for being one of the country's top cancer treatment and research facilities because of its ...

Squatty Potty

Launched in late 2011, Squatty Potty, LLC, (www.squattypotty.com) has created a safe, natural, simple solution that allows for easier elimination. The Squatty Potty offers a better bathroom experience by aligning the colon in a natural angle for faster, more effective colon evacuation. The Squatty Potty is designed to help assume the squatting position, wh...

AEterna Laboratories Incorporated

Æterna Laboratories Inc. is a biopharmaceutical company focused on the treatment of cancer. The company’s lead product, Neovastat®, is the focus of a number of clinical trials including pivotal trials for the treatment of lung and kidney cancer, and multiple myeloma, a type of blood cancer.

Opexa Therapeutics

Opexa Therapeutics is a commercialization driven biotechnology cellular therapy company that develops autologous personalized cell therapies for the treatment of various diseases. The Company is focused on its proprietary stem cell and T-cell technologies for the autologous use of peripheral blood derived adult stem cells in regenerative medicine as well as T cells for the treatment of autoimmune ...

Gilbert, Arizona Economic Development Division

Gilbert, Arizona announces new cancer research and treatment center and stem cell research and treatment center. Banner Health has joined with MD Anderson to deliver unprecedented levels of cancer care at the new Banner MD Anderson Cancer Center in Gilbert, Arizona. This unique collaboration represents the broadest extension of MD Anderson’s cancer ca...

Mitotix Incorporated

Mitotix is a privately held company focused on the discovery and development of therapeutic products for the treatment of diseases resulting from inappropriate cell proliferation. The Company's approach is based on Mitotix's unique understanding of the mechanisms that regulate the cell division cycle, the process by which cells grow, each replicating into two daughter cells. The Company's initial ...

Switch, Inc.

Headquartered in Seattle, Switch creates one-of-a-kind cardholder experiences that inspire loyalty, leading to recaptured and increased card revenue by keeping cards Top of Wallet. The company’s secure, proprietary and patent-pending automation technology gives cardholders the ability to manage and update all of their online accounts in one place. You...

Autolus Therapeutics Limited

Autolus is a clinical-stage biopharmaceutical company developing next-generation, programmed T cell therapies for the treatment of cancer. Using a broad suite of proprietary and modular T cell programming technologies, the company is engineering precisely targeted, controlled and highly active T cell therapies that are designed to better recognise cancer c...

Minerva Biotechnologies

Minerva Biotechnologies is a pioneer in the field of stem cells and cancer stem cells. Minerva was first to discover that cancer cells hijack an otherwise normal stem cell growth mechanism, involving a growth factor receptor called MUC1* (pronounced muk 1 star). By studying human stem cells in parallel with human cancer cells, Minerva scientists figured ou...

US Oncology Foundation

The Life Beyond Cancer Foundation advances cancer care in local communities by removing the barriers to prevention, education, early detection, treatment and survivorship. By working with local nonprofit and community organizations, the foundation helps cancer patients with funding for everyday living expenses and helps to educate the community about cancer prevention and early detection through l...

Protox Therapeutics Inc.

Protox Therapeutics is a product-focused development-stage company and a leader in advancing novel, targeted protein toxin therapeutics for the treatment of cancer and other proliferative diseases. Through the company’s INxin™ and PORxin™ technology platforms, therapeutic candidates are generated by engineering the naturally occurring toxins, Pseudomonas exotoxin and proaerolysin. These drug...

Cavion LLC

Cavion LLC is a privately held clinical stage platform pharmaceutical company creating therapies engaging the T-type calcium channel (Cav3) for the treatment of neurologic and oncologic diseases. The T-type calcium channel is an emerging molecular target for cancer and pain.

NantCell, Inc.

NantCell, an entity controlled by Dr. Patrick Soon-Shiong, is an immuno-oncology company focused on the discovery of innovative antibody, T cell and NK cell based treatments by developing molecularly targeted therapeutics, based on the proteomic profile of the patient's tumor, independent of the cancer's anatomical type.

Life Beyond Cancer Foundation

Started with seed money from US Oncology, the Life Beyond Cancer Foundation advances cancer care in local communities by removing the barriers to prevention, education, early detection, treatment and survivorship. By working with local nonprofit and community organizations, the foundation helps cancer patients with funding for everyday living expenses and helps to educate the community about cance...


More From BioPortfolio on "Cell type switch helps colon cancer evade treatment"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks